Access Pharmaceuticals, Inc. (ACCP) Cash Flow Statement

Click line-items for a historical chart and %

Net income (loss)	-14.87M
Gain on change in fair value of derivative - warrants
Loss on change in fair value of derivative - preferred stock
Gain on negotiated accounts payable
Depreciation and amortization	577K
Stock option compensation expense
Stock and warrants issued for services	0
Receivables	-491K
Prepaid expenses and other current assets	159K
Other assets	-4K
Accounts payable and accrued expenses
Dividends payable
Accrued interest payable
Deferred revenue	-452K
Net cash used in operating activities
Capital expenditures	-501K
Net cash used in investing activities
Proceeds from exercise of stock options
Proceeds from common stock issuances, net of costs	0
Net cash provided by financing activities
Net increase (decrease) in cash and cash equivalents	-8.95M
Cash and cash equivalents at beginning of period	40.14M
Cash and cash equivalents at end of period	31.19M
Cash paid for interest
Shares issued for dividends on preferred stock
Preferred stock dividends in dividends payable

Entities mentioned with ACCP

View All Entities